Related Scientific Literature
- Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review
- Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients
- Clinical Evaluation of Three Sample-To-Answer Platforms for the Detection of SARS-CoV-2
- Diagnostic performance of COVID-19 serology assays
- COVID-19 Special Column: Principles Behind the Technology for Detecting SARS-CoV-2, the Cause of COVID-19
- Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape
- Detection of COVID-19: A review of the current literature and future perspectives
- Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
- Current and Perspective Diagnostic Techniques for COVID-19
- Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
- Laboratory diagnosis of coronavirus disease-2019 (COVID-19)
- Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients
- Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2
- Comparison of two commercial molecular tests and a laboratory-developed modification of the CDC 2019-ncov reverse transcriptase PCR assay for the detection of sars-cov-2
- Clinical performance of sars-cov-2 molecular tests
- In vitro diagnostics of coronavirus disease 2019: Technologies and application
- Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence
- Current diagnostic tools for coronaviruses-From laboratory diagnosis to POC diagnosis for COVID-19
- Testing For SARS-CoV-2: The Day the World Turned its Attention to the Clinical Laboratory
- The outlook for diagnostic purposes of the 2019-novel coronavirus disease
- Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
- Evaluation of the COVID19 ID NOW EUA assay
- Trends and Innovations in Biosensors for COVID-19 Mass Testing
- Molecular diagnosis of COVID-19 in different biologic matrix, their diagnostic validity and clinical relevance: A systematic review
- Assay Techniques and Test Development for COVID-19 Diagnosis.
- Clinical Evaluation and Utilization of Multiple Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2
- Comparison of abbott id now, diasorin simplexa, and CDC fda emergency use authorization methods for the detection of sars-cov-2 from nasopharyngeal and nasal swabs from individuals diagnosed with covid-19
- Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
- Diagnostic Performance of a Rapid Point-of-care Test for SARS-CoV-2 in an Urban Emergency Department Setting
- Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport